It is not logical for a country regulator to not approve an available treatment in the middle of a pandemic because it also has severe/critical patients. That simple fact alone proves CD10 and Leronlimab were failures. Zero country went for Leronlimab or Cytodyn. Zero. Zero. Zero. Etc...